Global Drug Abuse Testing Market : Market Size, Competition Landscape, Opportunity, Trends, Regional Outlook, Historic, and Forecast Analysis, 2014 – 2029

$ PRICE - $ 3,000.00$ 8,900.00

Global Drug Abuse Testing Market: By Technology (Immunoassay, On-site Testing, Mass Spectrometry and Others), By Sample Type (Urine, Saliva, Blood, Hair and Others) and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Description

Drug Abuse Testing Market Description:

Drug abuse testing is conducted to detect the presence of illegal or prescription medications (taken for non-medical purpose) in the body. In drug testing, initially screening (qualitative) test is carried out by collecting urine, saliva, blood, and others. If the screening test is positive, the diagnostic laboratories carry out the confirmation test on the HPLC, LC-MS, GC-MS and others to quantify the presence of illegal or prescription medications. Drug abuse testing is carried out at schools, hospitals, transportation, mining, pre-employment, random testing, and post- accident testing, among others.

 

Drug Abuse Testing Market Size and Overview:

Global drug abuse testing market was valued at USD 2,161.6 Million in 2019 and projected to reach USD 2,818.3 Million. In terms of volume, globally around 229.2 Million drug abuse tests are carried out in 2019 and we anticipate it would reach 287.4 Million drug abuse tests by 2026. North America drug abuse testing market accounts to have highest market share followed by Europe region. In United States, about 124 Million of drug abuse tests are carried out in 2019 owing to increase in the awareness among the employers about drug abuse testing. Drug positivity rate in the USA drug abuse testing market is 6.6% in 2019. In North America, workforce testing accounts to have market share of 61%, followed by emergency room testing and pain management.

 

Europe drug abuse testing market was valued at USD 447.7 Million in 2018 and growing with a CAGR of 3.8% over the forecast period. In Europe, UK is the potential drug abuse testing market in comparison with other European countries. In 2018, more than 16 Million drug abuse tests are carried out in the UK market. In that, more than 15 Million are drug screening tests and one million are drug confirmation tests. Germany is another big market for drug testing in the Europe region, about 10 Million of drug abuse tests are carried out every year. In Europe, public and forensic laboratories usually carry out the drug abuse testing and workforce testing varies from country to country.

 

In terms of technology, Mass Spectrometry accounts to have USD 920.2 Million in 2018 followed by immunoassay and On-site testing. However, in terms of volume immunoassay and on-site testing dominates the drug abuse testing market.

 

Urine samples are mostly used in drug abuse testing market followed by saliva samples and blood samples. In 2019, urine drug screening value was accounted to USD 923.4 Million and saliva was USD 144.9 Million. Hair sample is preferred by the forensic laboratories and the sample may give for substances abused 90 days back. However, if the person has no hair or short hair, nail test is preferred by the forensic laboratories. Blood samples are used mainly in alcohol testing.

 

In 2016, Brazil enacted mandatory “wide window of detection” test for drugs of abuse, specifically hair testing. The Brazilian Federal Law No. 13.103 took effect on March 2, 2016 that mandates hair analysis drug testing for all professional truck, bus and large passenger van drivers renewing or obtaining licenses (Categories: C, D, E. In Brazil, truck drivers usually abuse drugs to awake during the driving. This law requires every brazil driver must pass the hair test to renew their license.

 

Impact of COVID -19 on Drug Abuse Testing Market

PBI anticipate that COVID-19 will have an impact on the drug abuse testing market in the 2020 as many European Nations, USA and other countries are in lockdown and that caused stalling of the economies across the globe. In addition, lab facilities and hospitals are crowded with COVID-19 tests and patients rather than the other tests. In 2020, PBI projects drug abuse testing market revenues will hit by 10-15% due to decrease in the workforce, supply chain issues, lack of laboratory resources & supplies and lockdowns across the nations. After lockdowns, PBI also anticipates that there would be in delay for the confirmation drug tests as the laboratories will be flooded with many numbers of tests after resuming operations from lockdowns.

 

Market Players Operating in Drug Abuse Testing Market :

Accuquik Test Kits, Advin Biotech, Alere, Inc. (Abbott), Alfa Scientific Designs, Inc., Andatech, ARK Diagnostics, Biopanda Reagents, Beckman Coulter, BTNX, Inc., Corolina Liquid Chemistries, Chromsystems, Inc., Co-Innovation Biotech Co., Ltd., Confirm Biosciences, Diagnostic Automation/Cortez Diagnostics Inc., Diasystems Scandinevia AB, Germaine Laboratories, Inc., Innovative Testing Solution, Immunostics, Inc., Medacx Ltd., Meridian Healthcare srl, Mossman Associates, Orasure Technologies, Inc., Pharmatech, Inc., Premier Biotech, Prospectol, Redwood Toxicology Laboratory, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Inc. Confirm Biosciences, and Neogen

 

Market Scope:

Drug Class

 

  • Opiates (6-Acetlycodeine, Acetylfentanyl, 6-monoacetylmorphine = 6-MAM, Carfentanil, Codeine, Dihydrocodeine, Dihydromorphine, Fentanyl, Hydrocodone, Hydromorphone, Meperidine, Morphine, Morphine-3-glucuronide, Morphine-6-glucuronide, N-desmethyltapentadol, Norcodeine, Norfentanyl, Norhydrocodone, Normeperidine, Noroxycodone, Noroxymorphone, O-Desmethyltramadol, Oxycodone, Oxymorphone, PPX Dextropropoxyphene, Naloxone, Tapentadol, Tilidine, Tramadol)

 

  • Amphetamines (Amphetamine, MBDB 3,4-Methylenedioxy-alpha-ethyl-N-Methylphenethylamine, MDA Methylenedioxyamphetamine, MDMA Methylenedioxymethamphetamine = Ecstasy, MDE = MDEA 3,4-Methylenedioxy-N-ethylamphetamine, Methamphetamine (Desoxyn), Paramethoxymetamphetamin = PMMA, Paramethoxyamphetamin = PMA, Femproporex, Amphepramone)

 

  • Alcohol Abuse (ETG Ethyl glucuronide, ETS Ethyl sulfate)

 

  • Cannabis (11-nor-9-carboxy-delta-9-tetrahydrocannabinol = THC-COOH, Cannabidiol, 9‑carboxy‑11‑nor‑Δ8 THC, 9‑carboxy‑11‑nor‑Δ9 THC glucuronide, Δ9-THC, 11-OH-Δ9-THC (THC-OH)

 

  • Cocaine (Cocaethylene, Cocaine, Ecgonine, Benzoylecgonine)

 

  • Benzodiazepines (3-hydroxyflubromazepam, 7-aminoflunitrazepam, 7-aminoclonazepam, 7-aminonitrazepam, Alpha hydroxyalprazolam, Alpha hydroxymidazolam, Alpha hydroxytriazolam, Alprazolam, Bentazepam, Bromazepam, Chlordiazepoxide, Citalopram, Clonazepam, Clonazolam, Clorazepate, Demoxepam, Desalkylflurazepam = Norazepam, Deschloroetizolam = Etizolam-2, Diazepam, Diclazepam (Ro5-3448) = Chlorazepam, Estazolam = desmethylalprazolam, Etizolam, Flubromazepam, Flubromazolam, Flunitrazepam, Flurazepam, Hydroxyethylfluorazepam, Lorazepam, Lorazepam glucuronide, Lormetazepam, Meclonazepam, Midazolam, N-desmethlychlordiazepoxid, Nifoxipam, Nitrazepam, Nordiazepam, Oxazepam, Oxazepam glucuronide, Phenazepam, Pyrazolam, Temazepam, Temazepam glucuronide, Triazolam, Zaleplon , Zolpidem, Zoplicone)

 

  • Antidepressants (Amitriptyline, Clomipramine, Cyclobenzaprine, Desmethylclomipramine, Desmethyldoxepin, Desmethylsertraline, Despramine, Doxepin, Fluoxetine – Nor fluoxetine, Imipramine, Maprotiline, Mianserin, Norclomipramine, Norfluoxetine, Nortrimipramine, Nortriptyline, Paroxetine, Protriptyline, Sertraline, Trimipramine)

 

  • Barbiturates (Amobarbital, Butalbital, Methohexital, Pentobarbital 2, Phenobarbital, Secbutabarbital, Secobarbital)

 

  • Designer Drugs (Mephedrone, Methylone , MDPV = 3,4-Methylenedioxypyrovalerone, Ketamine, JWH-018 = 1-pentyl-3-(1-naphthoyl)indole metabolite)

 

  • Heroin Substitution Panel (Buprenorphine, Buprenorphine-3-glucuronide, EDDP, Methadone, Norbuprenorphine, Norbuprenorphine-3-glucuronide)

 

  • LSD Derivatives (Lysergic Acid Diethylamide (LSD) 80%, 2-Oxo-3-hydroxy-LSD)

 

  • Methaqualone

 

Report Coverage:

  • DAT report covers the detailed level analysis of the drug class in terms of volume (tests) and value (USD Million)
  • Drug Abuse Testing Market report provides more than 10+ country-level analysis that includes quantitative and qualitative insights
  • DAT market report covers an in-depth level of market dynamics that includes drivers, restraints, opportunities, and trends
  • In the drug abuse testing market, we have identified the growth, mature, and low potential markets
  • The report covers the pricing analysis of reagents by the technology and sample type
  • DAT report covers more than 80+ analyte level sales and volume information by technology and sample type

 

Detailed Segmentation

 

Technology

  • Immunoassay
  • On-site Testing
  • Mass Spectrometry
  • Others

 

Sample Type

  • Urine
  • Saliva
  • Blood
  • Hair
  • Others

 

By Geography

 

  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Poland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • Gulf Cooperation Council (GCC) Countries
    • South Africa
    • Rest of MEA


Location

GEOGRAPHY

PBI Location Map

  • Accuquik Test Kits,
  • Advin Biotech
  • Alere, Inc. (Abbott)
  • Alfa Scientific Designs, Inc.
  • Andatech
  • ARK Diagnostics
  • Biopanda Reagents
  • Beckman Coulter
  • BTNX, Inc.
  • Corolina Liquid Chemistries
  • Chromsystems, Inc.
  • Co-Innovation Biotech Co., Ltd.
  • Confirm Biosciences
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • Diasystems Scandinevia AB
  • Germaine Laboratories, Inc.
  • Innovative Testing Solution
  • Immunostics, Inc.
  • Medacx Ltd.
  • Meridian Healthcare srl
  • Mossman Associates
  • Orasure Technologies, Inc.
  • Pharmatech, Inc.
  • Premier Biotech
  • Prospectol
  • Redwood Toxicology Laboratory
  • Roche Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc
  • Confirm Biosciences
  • Neogen

1. Executive Summary
2. Global Drug Abuse Testing Market Introduction
2.1. Global Drug Abuse Testing Market – Taxonomy
2.1.1. Drug Class Type
2.1.2. Sample Type
2.1.3. Technology
2.1.4. End User
3. Global Drug Abuse Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Drug Abuse Testing Market – Competition Landscape
4. Global Drug Abuse Testing Market Snapshot, 2018
4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. USA Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
5.1. Volume Breakdown by Sample Type – 2018
5.1.1. Urine
5.1.2. Saliva
5.1.3. Hair
5.1.4. Blood
5.1.5. Others
5.2. Volume Breakdown by Technology – 2018
5.2.1. Immunoassay
5.2.2. Onsite Testing
5.2.3. Mass Spectrometry
5.2.4. Others
5.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
5.3.1. Amphetamines
5.3.2. Barbiturates
5.3.3. Cannabinoids
5.3.4. Cocaine
5.3.5. Alcohol Abuse
5.3.6. Heroin Substitution Panel
5.3.7. LSD
5.3.8. Designer Drugs
5.3.9. Benzodiazepines
5.3.10. Opiates
5.3.11. Antidepressants
6. Canada Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
6.1. Volume Breakdown by Sample Type – 2018
6.1.1. Urine
6.1.2. Saliva
6.1.3. Hair
6.1.4. Blood
6.1.5. Others
6.2. Volume Breakdown by Technology – 2018
6.2.1. Immunoassay
6.2.2. Onsite Testing
6.2.3. Mass Spectrometry
6.2.4. Others
6.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
6.3.1. Amphetamines
6.3.2. Barbiturates
6.3.3. Cannabinoids
6.3.4. Cocaine
6.3.5. Alcohol Abuse
6.3.6. Heroin Substitution Panel
6.3.7. LSD
6.3.8. Designer Drugs
6.3.9. Benzodiazepines
6.3.10. Opiates
6.3.11. Antidepressants
7. Germany Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
7.1. Volume Breakdown by Sample Type – 2018
7.1.1. Urine
7.1.2. Saliva
7.1.3. Hair
7.1.4. Blood
7.1.5. Others
7.2. Volume Breakdown by Technology – 2018
7.2.1. Immunoassay
7.2.2. Onsite Testing
7.2.3. Mass Spectrometry
7.2.4. Others
7.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
7.3.1. Amphetamines
7.3.2. Barbiturates
7.3.3. Cannabinoids
7.3.4. Cocaine
7.3.5. Alcohol Abuse
7.3.6. Heroin Substitution Panel
7.3.7. LSD
7.3.8. Designer Drugs
7.3.9. Benzodiazepines
7.3.10. Opiates
7.3.11. Antidepressants
8. France Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
8.1. Volume Breakdown by Sample Type – 2018
8.1.1. Urine
8.1.2. Saliva
8.1.3. Hair
8.1.4. Blood
8.1.5. Others
8.2. Volume Breakdown by Technology – 2018
8.2.1. Immunoassay
8.2.2. Onsite Testing
8.2.3. Mass Spectrometry
8.2.4. Others
8.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
8.3.1. Amphetamines
8.3.2. Barbiturates
8.3.3. Cannabinoids
8.3.4. Cocaine
8.3.5. Alcohol Abuse
8.3.6. Heroin Substitution Panel
8.3.7. LSD
8.3.8. Designer Drugs
8.3.9. Benzodiazepines
8.3.10. Opiates
8.3.11. Antidepressants
9. UK Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
9.1. Volume Breakdown by Sample Type – 2018
9.1.1. Urine
9.1.2. Saliva
9.1.3. Hair
9.1.4. Blood
9.1.5. Others
9.2. Volume Breakdown by Technology – 2018
9.2.1. Immunoassay
9.2.2. Onsite Testing
9.2.3. Mass Spectrometry
9.2.4. Others
9.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
9.3.1. Amphetamines
9.3.2. Barbiturates
9.3.3. Cannabinoids
9.3.4. Cocaine
9.3.5. Alcohol Abuse
9.3.6. Heroin Substitution Panel
9.3.7. LSD
9.3.8. Designer Drugs
9.3.9. Benzodiazepines
9.3.10. Opiates
9.3.11. Antidepressants
9.3.12. Methaqualone
10. Italy Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
10.1. Volume Breakdown by Sample Type – 2018
10.1.1. Urine
10.1.2. Saliva
10.1.3. Hair
10.1.4. Blood
10.1.5. Others
10.2. Volume Breakdown by Technology – 2018
10.2.1. Immunoassay
10.2.2. Onsite Testing
10.2.3. Mass Spectrometry
10.2.4. Others
10.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
10.3.1. Amphetamines
10.3.2. Cannabinoids
10.3.3. Cocaine
10.3.4. Alcohol Abuse
10.3.5. Heroin Substitution Panel
10.3.6. Benzodiazepines
10.3.7. Opiates
10.3.8. Antidepressants
11. Spain Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
11.1. Volume Breakdown by Sample Type – 2018
11.1.1. Urine
11.1.2. Saliva
11.1.3. Hair
11.1.4. Blood
11.1.5. Others
11.2. Volume Breakdown by Technology – 2018
11.2.1. Immunoassay
11.2.2. Onsite Testing
11.2.3. Mass Spectrometry
11.2.4. Others
11.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
11.3.1. Amphetamines
11.3.2. Barbiturates
11.3.3. Cannabinoids
11.3.4. Cocaine
11.3.5. Alcohol Abuse
11.3.6. Heroin Substitution Panel
11.3.7. LSD
11.3.8. Designer Drugs
11.3.9. Benzodiazepines
11.3.10. Opiates
11.3.11. Antidepressants
12. Switzerland Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
12.1. Volume Breakdown by Sample Type – 2018
12.1.1. Urine
12.1.2. Saliva
12.1.3. Hair
12.1.4. Blood
12.1.5. Others
12.2. Volume Breakdown by Technology – 2018
12.2.1. Immunoassay
12.2.2. Onsite Testing
12.2.3. Mass Spectrometry
12.2.4. Others
12.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
12.3.1. Amphetamines
12.3.2. Barbiturates
12.3.3. Cannabinoids
12.3.4. Cocaine
12.3.5. Alcohol Abuse
12.3.6. Heroin Substitution Panel
12.3.7. LSD
12.3.8. Designer Drugs
12.3.9. Benzodiazepines
12.3.10. Opiates
12.3.11. Antidepressants
13. Austria Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
13.1. Volume Breakdown by Sample Type – 2018
13.1.1. Urine
13.1.2. Saliva
13.1.3. Hair
13.1.4. Blood
13.1.5. Others
13.2. Volume Breakdown by Technology – 2018
13.2.1. Immunoassay
13.2.2. Onsite Testing
13.2.3. Mass Spectrometry
13.2.4. Others
13.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
13.3.1. Amphetamines
13.3.2. Barbiturates
13.3.3. Cannabinoids
13.3.4. Cocaine
13.3.5. Alcohol Abuse
13.3.6. Heroin Substitution Panel
13.3.7. LSD
13.3.8. Designer Drugs
13.3.9. Benzodiazepines
13.3.10. Opiates
13.3.11. Antidepressants
14. China Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
14.1. Volume Breakdown by Sample Type – 2018
14.1.1. Urine
14.1.2. Saliva
14.1.3. Hair
14.1.4. Blood
14.1.5. Others
14.2. Volume Breakdown by Technology – 2018
14.2.1. Immunoassay
14.2.2. Onsite Testing
14.2.3. Mass Spectrometry
14.2.4. Others
14.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
14.3.1. Amphetamines
14.3.2. Barbiturates
14.3.3. Cannabinoids
14.3.4. Cocaine
14.3.5. Alcohol Abuse
14.3.6. Heroin Substitution Panel
14.3.7. LSD
14.3.8. Designer Drugs
14.3.9. Benzodiazepines
14.3.10. Opiates
14.3.11. Antidepressants
15. Korea Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
15.1. Volume Breakdown by Sample Type – 2018
15.1.1. Urine
15.1.2. Saliva
15.1.3. Hair
15.1.4. Blood
15.1.5. Others
15.2. Volume Breakdown by Technology – 2018
15.2.1. Immunoassay
15.2.2. Onsite Testing
15.2.3. Mass Spectrometry
15.2.4. Others
15.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
15.3.1. Amphetamines
15.3.2. Barbiturates
15.3.3. Cannabinoids
15.3.4. Cocaine
15.3.5. Alcohol Abuse
15.3.6. Heroin Substitution Panel
15.3.7. LSD
15.3.8. Designer Drugs
15.3.9. Benzodiazepines
15.3.10. Opiates
15.3.11. Antidepressants
16. Australia Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
16.1. Volume Breakdown by Sample Type – 2018
16.1.1. Urine
16.1.2. Saliva
16.1.3. Hair
16.1.4. Blood
16.1.5. Others
16.2. Volume Breakdown by Technology – 2018
16.2.1. Immunoassay
16.2.2. Onsite Testing
16.2.3. Mass Spectrometry
16.2.4. Others
16.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
16.3.1. Amphetamines
16.3.2. Cannabinoids
16.3.3. Cocaine
16.3.4. Alcohol Abuse
16.3.5. Heroin Substitution Panel
16.3.6. Designer Drugs
16.3.7. Benzodiazepines
16.3.8. Opiates
16.3.9. Antidepressants
17. Brazil Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
17.1. Volume Breakdown by Sample Type – 2018
17.1.1. Urine
17.1.2. Saliva
17.1.3. Hair
17.1.4. Blood
17.1.5. Others
17.2. Volume Breakdown by Technology – 2018
17.2.1. Immunoassay
17.2.2. Onsite Testing
17.2.3. Mass Spectrometry
17.2.4. Others
17.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
17.3.1. Amphetamines
17.3.2. Barbiturates
17.3.3. Cannabinoids
17.3.4. Cocaine
17.3.5. Alcohol Abuse
17.3.6. Heroin Substitution Panel
17.3.7. Designer Drugs
17.3.8. Benzodiazepines
17.3.9. Opiates
17.3.10. Antidepressants
18. Central America Drug Abuse Testing Market, 2014 – 2018 and Forecast, 2019 – 2029 (Volume and Value)
18.1. Volume Breakdown by Sample Type – 2018
18.1.1. Urine
18.1.2. Saliva
18.1.3. Hair
18.1.4. Blood
18.1.5. Others
18.2. Volume Breakdown by Technology – 2018
18.2.1. Immunoassay
18.2.2. Onsite Testing
18.2.3. Mass Spectrometry
18.2.4. Others
18.3. Drug Abuse Testing Market – 2018, by Drug Class, Market Volume (‘000 Tests) and Market Value (‘000 US$)
18.3.1. Amphetamines
18.3.2. Barbiturates
18.3.3. Cannabinoids
18.3.4. Cocaine
18.3.5. Alcohol Abuse
18.3.6. Heroin Substitution Panel
18.3.7. LSD
18.3.8. Designer Drugs
18.3.9. Benzodiazepines
18.3.10. Opiates
18.3.11. Antidepressants

List of Figures
Figure 1: Global Drug Abuse Testing Market Value (USD Million), 2014 – 2029
Figure 2: Overview of the Drug Abuse Testing Market Value (USD Million), 2018
Figure 3: Drug Abuse Testing Market by Technology Value Breakdown (2018)
Figure 4: Drug Abuse Testing Market Share by End User, 2018
Figure 5: DAT Market by Sample Type (USD Million), 2018
Figure 6: Volume Breakdown of Drug Classes (2018)
Figure 7: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 8: Volume Breakdown of Drug Screening by Sample Type
Figure 9: USA Drug Abuse Testing Market Value (USD ‘Million) and Volume (‘000), 2014 – 2029
Figure 10: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 11: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 12: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 13: Canada Drug Abuse Testing Market Value (USD Million), 2015 – 2026
Figure 14: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 15: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 16: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 17: Germany Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 18: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 19: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 20: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 21: France Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 22: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 23: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 24: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 25: UK Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 26: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 27: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 28: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 29: Italy Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 30: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 31: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 32: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 33: Spain Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 34: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 35: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 36: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 37: Switzerland Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 38: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 39: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 40: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 41: Austria Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 42: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 43: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 44: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 45: China Drug Abuse Testing Market Value (USD Million), 2015 – 2026
Figure 46: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 47: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 48: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 49: Korea Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 50: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 51: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 52: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 53: Australia Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 54: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 55: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 56: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 57: Brazil Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029
Figure 58: Volume Breakdown of Drug Class (2018) – Confirmation Samples
Figure 59: Volume Breakdown of Drug Screening Vs Confirmation (2018)
Figure 60: Volume Breakdown of Drug Screening by Sample Type, 2018
Figure 61: Central America Drug Abuse Testing Market Value (USD ‘000) and Volume (‘000), 2014 – 2029

List of Tables
Table 1: USA Drug Abuse Testing Market Volume (Million), 2014 – 2029
Table 2: USA Drug Abuse Testing Market Value (Million), 2014 – 2029
Table 3: USA Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 4: USA Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 5: Canada Drug Abuse Testing Market Volume (Million), 2014 – 2029
Table 6: Canada Drug Abuse Testing Market Value (Million), 2014 – 2029
Table 7: Canada Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 8: Canada Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 9: Germany Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 10: Germany Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 11: Germany Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 12: Germany Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 13: France Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 14: France Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 15: France Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 16: France Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 17: UK Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 18: UK Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 19: UK Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 20: UK Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 21: Italy Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 22: Italy Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 23: Italy Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 24: Italy Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 25: Spain Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 26: Spain Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 27: Spain Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 28: Spain Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 29: Switzerland Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 30: Switzerland Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 31: Switzerland Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 32: Switzerland Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 33: Austria Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 34: Austria Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 35: Austria Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 36: Austria Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 37: China Drug Abuse Testing Market Volume (Million), 2014 – 2029
Table 38: China Drug Abuse Testing Market Value (Million), 2014 – 2029
Table 39: China Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 40: China Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 41: Korea Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 42: Korea Drug Abuse Testing Market – Drug Screening Value, 2014 – 2029
Table 43: Korea Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 44: Korea Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 45: Australia Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 46: Australia Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 47: Australia Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 48: Australia Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 49: Brazil Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 50: Brazil Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 51: Brazil Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 52: Brazil Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029
Table 53: Central America Drug Abuse Testing Market – Drug Screening Volume, 2014 – 2029
Table 54: Central America Drug Abuse Testing Market – Drug Screening Value (USD), 2014 – 2029
Table 55: Central America Drug Abuse Testing (DAT) Market- Historical, Forecast Market Volume (Tests), 2014-2029
Table 56: Central America Drug Abuse Testing (DAT) Market- Historical, Forecast Market Value (‘000 US$), 2014-2029

Ask An Analyst

Request Customisation

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX